Biocon Biologics starts clinical trial of drug for severe covid-19 complications

In 2013, the company had received DCGI approval for the drug after successful clinical studies including a Phase 3 study in plaque psoriasis, and it launched the product under the brand Alzumab

from Livemint - Science https://ift.tt/2ZUEyTU